We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Advanced Cell Diagnostics and Definiens Develop Quantitative Biomarker Tools

By LabMedica International staff writers
Posted on 25 Apr 2011
A technological leader in molecular pathology, Advanced Cell Diagnostics (ACD; Hayward, CA, USA), has partnered with a provider for biomedical imaging and data analyses.

The biomedical image company Definiens (Munich, Germany) will develop a unique and proprietary image analysis application for ACD that provides users with powerful analysis capabilities.

Under the agreement, Definiens will develop a unique and proprietary image analysis application for ACD that provides users with powerful analysis capabilities. Definiens software, based on its Definiens XD framework, offers users with accurate, robust, and scalable image analysis solutions for a wide range of histology analysis. The strategic partnership will develop image analysis applications that will enable scientists to quantify specific ribonucleic acid (RNA) molecules accurately within individual cells in routine clinical specimen. The joint venture will build on ACD's RNAscope platform and add new specialized image analysis solutions that will automatically process and analyze images from RNAscope assays.

ACD's RNAscope is a novel and proprietary RNA in situ hybridization (ISH) method that can detect and quantify virtually any expressed gene at single molecule sensitivity in individual cells in all major biological specimen types, including cell lines, peripheral blood mononuclear cells and formalin-fixed paraffin embedded tissue sections. As the most clinically robust RNA ISH assay available, RNAscope enables the fastest path from genomic discovery to validated biomarkers and clinical diagnostic tests.

Yuling Luo, PhD, president and CEO of ACD, said, "This advanced image analysis solution will bring objective and accurate quantification to RNAscope and enable a new generation of diagnostic applications such as circulating tumor cell detection and molecular analysis. For the first time, gene expression can be measured quantitatively at single cell resolution and interpreted by pathologists within histopathological context."

Related Links:

Advanced Cell Diagnostics
Definiens



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
HPV Test
Allplex HPV28 Detection
New
Gold Member
Platelet Function Analyzer
PL-12

Latest Industry News

New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers
25 Apr 2011  |   Industry

Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada
25 Apr 2011  |   Industry

Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial
25 Apr 2011  |   Industry